Fig. 5.
Expansion of CD11c+ DCs in the PB of FL-treated individuals.
(A) Increase in total numbers of CD11c+ DCs over time in FL-treated (•, ▴, ▪) and placebo-treated (○) individuals from the cohort receiving a dose of 100 μg · kg−1 · d−1. Similar results were obtained in the cohorts receiving 10, 25, 50, and 75 μg/kg. (B) Number of CD11c+ DCs detected at day 15 in each FL-treated or placebo-treated (*) individual from each dose cohort.
